Psychiatry and Neurology, Neurology · Winston Salem, NC
NPI
1386667343
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
190 Kimel Park Dr Ste 120
Winston Salem, NC, 27103
Phone (336) 277-2200
Groups this clinician bills Medicare through
Medicare paid, 2024
$58K
778 services
Medicare patients, 2024
382
Average age 74
Drug cost, 2024
$5.7M
6,541 prescriptions
Company payments, 2025
$36K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert S Meadows was code 99215 (office e&m - established), 211 times for 144 patients. In total Robert S Meadows billed 778 services in 33 codes, and Medicare paid $58K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 211 | 144 | $95.68 | $20K |
| 99214 Office E&M - Established | Facility | 164 | 131 | $66.45 | $11K |
| 95886 Electrical Nerve Conductivity | Facility | 48 | 48 | $26.49 | $1,271 |
| 99205 Office E&M - New | Facility | 42 | 42 | $128.91 | $5,414 |
| 99223 Hospital E&M - Initial | Facility | 34 | 33 | $123.25 | $4,190 |
| 95910 Electrical Nerve Conductivity | Facility | 25 | 25 | $65.49 | $1,637 |
| 99213 Office E&M - Established | Facility | 21 | 15 | $48.17 | $1,012 |
| 99204 Office E&M - New | Facility | 19 | 19 | $96.99 | $1,843 |
| 95913 Electrical Nerve Conductivity | Facility | 18 | 18 | $112.85 | $2,031 |
| 99214 Office E&M - Established | Office | 13 | 11 | $62.66 | $815 |
| 95912 Electrical Nerve Conductivity | Facility | 12 | 12 | $102.16 | $1,226 |
| 95885 Electrical Nerve Conductivity | Facility | 12 | 12 | $12.89 | $155 |
By year: 2022 $89K for 1,142 services; 2023 $83K for 1,100 services; 2024 $58K for 778 services.
Medicare prescription drug claims, 2024
In 2024, the drug Robert S Meadows prescribed most often to Medicare patients was Gabapentin, with 434 prescriptions and refills. In total Robert S Meadows wrote 6,541 Medicare prescriptions that cost $5.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 434 | 754 | 103 | $7,692 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 336 | 693 | 78 | $7,612 |
| Clonazepam Generic | 250 | 283 | 48 | $2,107 |
| Primidone Generic | 243 | 548 | 67 | $7,515 |
| Levetiracetam Generic | 229 | 480 | 51 | $6,128 |
| Donepezil Hcl Generic | 226 | 424 | 57 | $1,271 |
| Memantine Hcl Generic | 226 | 394 | 56 | $4,678 |
| Pregabalin Generic | 222 | 245 | 41 | $3,778 |
| Ropinirole Hcl Generic | 213 | 372 | 49 | $2,822 |
| Rivastigmine Rivastigmine Tartrate | 182 | 309 | 35 | $9,696 |
| Alprazolam Generic | 171 | 172 | 24 | $953 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 167 | 379 | 46 | $5,077 |
| Trazodone Hcl Generic | 114 | 166 | 27 | $743 |
| Nurtec Odt Rimegepant Sulfate | 110 | 110 | 22 | $166K |
| Cyclobenzaprine Hcl Generic | 109 | 147 | 26 | $735 |
Brand drugs: - claims; generic drugs: 5,531 claims; opioid claims: 99.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert S Meadows $36K ($36K in general payments such as food, travel and fees) from 15 companies. The largest payer was Lilly USA, LLC with $33K.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 47 | $33K |
| EMD Serono, Inc. MRK.DE | 14 | $693 |
| Boston Scientific Corporation BSX | 2 | $528 |
| Abbvie Inc. ABBV | 52 | $518 |
| Teva Pharmaceuticals USA, Inc. TEVA | 33 | $466 |
| Pfizer Inc. PFE | 25 | $223 |
| MDD US Operations, LLC | 15 | $158 |
| Alexion Pharmaceuticals, Inc. AZN | 1 | $85.62 |
| Amneal Pharmaceuticals LLC AMRX | 2 | $55.6 |
| LivaNova USA, Inc. LIVN | 1 | $36.65 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.